The impact of a pathologist's personality on the interobserver variability and diagnostic accuracy of predictive PD-L1 immunohistochemistry in lung cancer

Autor: Rogier Butter, Liesbeth M. Hondelink, Lisette van Elswijk, Johannes L.G. Blaauwgeers, Elisabeth Bloemena, Rieneke Britstra, Nicole Bulkmans, Anna Lena van Gulik, Kim Monkhorst, Mathilda J. de Rooij, Ivana Slavujevic-Letic, Vincent T.H.B.M. Smit, Ernst-Jan M. Speel, Erik Thunnissen, Jan H. von der Thüsen, Wim Timens, Marc J. van de Vijver, David C.Y. Yick, Aeilko H. Zwinderman, Danielle Cohen, Nils A. 't Hart, Teodora Radonic

Publikováno v: Butter, R, Hondelink, L M, van Elswijk, L, Blaauwgeers, J L G, Bloemena, E, Britstra, R, Bulkmans, N, van Gulik, A L, Monkhorst, K, de Rooij, M J, Slavujevic-Letic, I, Smit, V T H B M, Speel, E-J M, Thunnissen, E, von der Thusen, J H, Timens, W, van de Vijver, M J, Yick, D C Y, Zwinderman, A H, Cohen, D, 't Hart, N A & Radonic, T 2022, ' The impact of a pathologist's personality on the interobserver variability and diagnostic accuracy of predictive PD-L1 immunohistochemistry in lung cancer ', Lung Cancer, vol. 166, pp. 143-149 . https://doi.org/10.1016/j.lungcan.2022.03.002
Lung Cancer, 166, 143-149. ELSEVIER IRELAND LTD
Lung Cancer, 166, 143-149. Elsevier Ireland Ltd
Lung cancer (Amsterdam, Netherlands), 166, 143-149. Elsevier Ireland Ltd

OBJECTIVES: Programmed death-ligand 1 (PD-L1) is the only approved predictive biomarker for immunotherapy in non-small cell lung cancer (NSCLC). However, predictive PD-L1 immunohistochemistry is subject to interobserver variability. We hypothesized t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e91c4dfdf95aaf2d5c8858a92d701a4
https://research.vumc.nl/en/publications/b0a56853-9990-4cd8-bc42-214dd162e9ce